bioRxivCancer BiologyPreprint
TACSTD2 expression marks the early transition to colon adenomas
Anna SiskovaiD, K HuebneriD, Giulio FerreroiD, Annemarie Gehring, Chuanpit Hampel, Alessio NaccaratiiD, Barbara PardiniiD, Sonia TaralloiD, Carol Immanuel Geppert, Jan ProcházkaiD, Jolana TurečkováiD, Jiri Jungwirth, Tomáš HucliD, Jan KráliD, Ľudmila VodičkováiD, Katharina Erlenbach‐Wuensch, Arndt HartmanniD, Katerina Honkova, Radoslav MatějiD, Pavel VodičkaiD, Veronika Polakova VymetalkovaiD, Regine Schneider‐StockiD
Abstract
This study aimed to address new molecular events occurring in precancerous stages of colorectal cancer (CRC) by integrated analysis of gene expression data and DNA methylation profiles. Whole-transcriptome sequencing analysis was performed on 16 fresh frozen colorectal adenoma and matched mucosa specimens along with validation of candidates in an independent cohort of 20 fresh frozen paired adenoma and adjacent mucosa tissues as well as eight independent public datasets (335 cases). Genome-wide methylation profiles were determined for 5 adenoma pairs and confirmed by pyrosequencing on 20 tissue pairs used for validation. Functional analysis was performed in vitro and in vivo using the inflammation-associated azoxymethane/dextran sodium sulfate (AOM/DSS) and the sporadic colorectal carcinogenesis (six AOM injections) mouse models as well as ApcMin/+ mice. Candidates were investigated by immunohistochemical staining of human adenomas and early-stage (pT1) CRC tumors. A total of 1,917 differentially expressed genes and 148,191 differentially methylated CpG sites were detected in adenomas compared with adjacent mucosa samples. Based on the transcriptome data and relevance to CRC, TACSTD2, MMP7, MMP1, CLDN2, CLDN1, and ETV4, were selected for further validation. TACSTD2 promoter hypomethylation in adenoma tissues was validated in 20 additional tissue pairs and corresponded with increased TACSTD2 expression. TACSTD2 was also overexpressed in an in vitro transformation model of human colonic epithelial cells. The TACSTD2 protein TROP2 was elevated in human adenomas, pT1 tumors, and in murine adenomas, while it was absent in the unaffected adjacent mucosa. TROP2 overexpression might trigger the development of precancerous lesions and could help identify early transformation foci in colon biopsies. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=110 SRC="FIGDIR/small/620817v1_ufig1.gif" ALT="Figure 1"> View larger version (34K): org.highwire.dtl.DTLVardef@1f23753org.highwire.dtl.DTLVardef@10e6abeorg.highwire.dtl.DTLVardef@181f500org.highwire.dtl.DTLVardef@fc0d38_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- organism: mouse
- assay: bulk RNA-seq
- assay: DNA methylation
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TROP2 represents a negative prognostic factor in colorectal adenocarcinoma and its expression is associated with features of epithelial-mesenchymal transition and invasiveness
J. Svec, M. Stastna, … V. Korinek·bioRxiv·Jul 27, 2022
- TET1 and TDG suppress intestinal tumorigenesis by down regulating the inflammatory and immune response pathways
R. Tricarico, J. Madzo, … A. Bellacosa·bioRxiv·Jun 21, 2019
- Colorectal adenoma presence is associated with decreased menaquinone pathway functions in the gut microbiome of patients undergoing routine colonoscopy
Ilona Vilkoite, Ivars Silamiķelis, … Laila Silamiķele·PLoS ONEPeer-reviewed·Mar 11, 2026
- Integrated microbiome and metabolomic profiling reveals alterations across the adenoma-colorectal cancer sequence
Tien-En Chang, Hung‐Hsin Lin, … Ming‐Chih Hou·Microbiology SpectrumPeer-reviewed·Oct 26, 2026
- Human colorectal pre-cancer atlas identifies distinct molecular programs underlying two major subclasses of pre-malignant tumors
B. Chen, E. T. McKinley, … K. Lau·bioRxiv·Jan 11, 2021
- Loss of WNT2B Increases Progression from Dysplasia to Colorectal Cancer
Luiz Fernando Silva Oliveira, Yu-Syuan Wu, … Amy E. O’Connell·bioRxiv·Aug 21, 2025